PureTech to develop drug to treat lung scarring in COVID-19 patientsUS biotech PureTech is to develop its most advanced pipeline drug LYT-100 as a potential treatment for inflammation and Share XPureTech to develop drug to treat lung scarring in COVID-19 patientshttps://pharmaphorum.com/news/puretech-to-develop-drug-to-treat-lung-scarring-in-covid-19-patients/
